301211 亨迪藥業
按盤價 
15.280 +0.380 (+2.550%)
15.280 +0.380 (+2.550%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.916 | 3.924 | 7.602 | 5.592 | 8.323 |
| 總資產報酬率 ROA (%) | 0.856 | 3.636 | 6.981 | 5.210 | 7.764 |
| 投入資產回報率 ROIC (%) | 0.906 | 3.871 | 7.409 | 5.477 | 8.244 | 邊際利潤分析 |
| 銷售毛利率 (%) | 20.535 | 28.841 | 40.172 | 28.878 | 33.943 |
| 營業利潤率 (%) | 7.433 | 22.626 | 30.969 | 28.884 | 25.764 |
| 息稅前利潤/營業總收入 (%) | 4.694 | 11.378 | 22.955 | 15.967 | 26.040 |
| 淨利潤/營業總收入 (%) | 6.564 | 20.533 | 26.562 | 24.430 | 22.502 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 1.226 | 78.540 | 96.296 | 94.033 | 84.775 |
| 價值變動淨收益/利潤總額(%) | 94.658 | 18.950 | 1.982 | 0.000 | 7.691 |
| 營業外收支淨額/利潤總額(%) | -2.543 | -0.461 | -1.242 | -0.871 | -0.073 | 償債能力分析 |
| 流動比率 (X) | 13.952 | 11.404 | 11.984 | 10.660 | 20.670 |
| 速動比率 (X) | 12.996 | 10.565 | 10.992 | 10.111 | 19.802 |
| 資產負債率 (%) | 5.921 | 7.191 | 7.457 | 8.895 | 4.614 |
| 帶息債務/全部投入資本 (%) | 0.523 | 0.489 | 0.932 | 2.985 | 0.271 |
| 股東權益/帶息債務 (%) | 18,887.427 | 20,215.891 | 10,560.344 | 3,230.841 | 36,672.936 |
| 股東權益/負債合計 (%) | 1,588.977 | 1,290.566 | 1,241.104 | 1,024.271 | 2,067.151 |
| 利息保障倍數 (X) | -1.837 | -1.021 | -3.007 | -1.260 | 88.477 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 38.513 | 40.804 | 33.696 | 70.748 | 72.624 |
| 存貨周轉天數 (天) | 138.441 | 176.813 | 130.916 | 100.365 | 112.946 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 14/11/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
